SCM
IMMU

Sio Capital Management’s Immunomedics Inc IMMU Stock Holding History

Sio Capital Management’s Portfolio IMMU Stock Details IMMU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-70,000
Closed -$971K – 93
2019
Q2 		$971K Buy
+70,000
New +$1.05M 0.23% 63
2019
Q1 		– Sell
-25,900
Closed -$370K – 90
2018
Q4 		$370K Buy
+25,900
New +$514K 0.13% 66
2017
Q1 		– Sell
-506,978
Closed -$1.86M – 69
2016
Q4 		$1.86M Buy
+506,978
New +$1.5M 1.09% 35

Other funds holding IMMU

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
RM
RP Management New York $139M AUM 37.98% 1-Year Est. Return

Sio Capital Management's IMMU Position: Q3 2019 in Review

Sio Capital Management sold out of Immunomedics Inc (IMMU) in Q3 2019, closing a stake of 70,000 shares — an estimated $971K sold.

Sio Capital Management first reported a position in IMMU in Q4 2016 and held it in 3 quarters. The position peaked at $1.86M in Q4 2016. 208 funds tracked by Wall St. Rank hold IMMU as of Q3 2019.

  • Sio Capital Management reported no remaining Immunomedics Inc position as of Q3 2019 after selling out during the quarter.
  • Sio Capital Management sold 70,000 Immunomedics Inc shares in Q3 2019, an estimated $971K.
  • Sio Capital Management first reported a position in Immunomedics Inc in Q4 2016 and held it in 3 quarters.
  • Sio Capital Management's Immunomedics Inc position peaked at $1.86M in Q4 2016.
  • 208 funds tracked by Wall St. Rank held Immunomedics Inc as of Q3 2019.

Based on Sio Capital Management's 13F filing for Q3 2019, filed 14 Nov 2019.